|

Ketamine (0.5 mg/kg) Clinical Trials

1 actively recruiting trial across 1 location

No change since August 2026

Also known as: Ketalar, Ketamine hydrochloride

Pipeline

Phase 2: 1

Top Sponsors

  • Hospital Italiano de Buenos Aires1

Indications

  • Depression Disorder1
  • Ketamine1
  • Critical Illness1
  • Depressive Symptoms1
  • Depression1

Jacksonville, Florida1 trial

Subanesthetic Ketamine Infusions for Depressive Symptoms in Intensive Care Unit Patients

Mayo Clinic

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.